Actively Recruiting
Study of the Impact of Frequency of Changing PICCline Dressings in Patients With Acute Leukemia
Led by Centre Hospitalier Universitaire de Nīmes · Updated on 2025-04-14
60
Participants Needed
1
Research Sites
221 weeks
Total Duration
On this page
Sponsors
C
Centre Hospitalier Universitaire de Nīmes
Lead Sponsor
U
University Hospital, Montpellier
Collaborating Sponsor
AI-Summary
What this Trial Is About
Peripherally Inserted Central Catheters have been widely used for many years for the administration of chemotherapy to patients with cancer. However, its use entails significant infectious complications and high risks of death.The hypothesis is that increasing the rate of PICCline dressing changes will reduce the occurrence of catheter-related infections.
CONDITIONS
Official Title
Study of the Impact of Frequency of Changing PICCline Dressings in Patients With Acute Leukemia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient with a diagnosis of acute myeloblastic leukemia.
- Patient undergoing intensive induction chemotherapy causing high risk of severe infection defined as profound neutropenia (Polymorphonuclear neutrophil count <500/mm3) lasting more than 7 days.
- Patient who has had a PICCline placed within the last 24 hours or requires PICCline placement during hospitalization under optimal hygiene and asepsis conditions.
- Patient housed in a protected environment (flow chamber or Plasmair��).
- Patient who has given free and informed consent.
- Patient affiliated or beneficiary of a health insurance plan.
- Adult patient (18 years old or older).
You will not qualify if you...
- Patient with PICCline placed during a previous hospitalization.
- Patient in an exclusion period determined by another study.
- Patient under court protection, guardianship, or curatorship.
- Patient unable to give consent.
- Patient for whom it is impossible to give informed information.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU de Montpellier Hôpital St-Eloi
Montpellier, France, 34090
Actively Recruiting
Research Team
É
Éric JOURDAN, Dr.
CONTACT
A
Anissa MEGZARI
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here